Clinical Education Conference

Clinical Education Conference for apps, nurses, and fellows


The Clinical Education Conference for APPs, Nurses, and Fellows is a 2.5-day program that provides attendees with a deeper understanding of the diagnostic evaluations and therapeutic treatments for acute and chronic complications of blood and marrow transplantation and cellular therapies. Attendees have the opportunity to participate in breakout sessions that will dig deeper into case studies and treatments of either the adult and pediatric patient populations.


Details

Thursday, October 13 - Saturday, October 15

Hyatt Regency Miami
Miami, Florida 


Registration

Register

Registration Type Price
ASTCT Member Rate $350
Non-ASTCT Member Rate $400
ASTCT New Affiliate Membership* + CEC Registration
  • Registration rate: $350
  • Membership payment: $100
*Option saves $50 on membership. Membership term is valid early September 2022 - December 2023. Only available to first time members or those with lapsed membership. 
$450


All cancellations and/or refunds must be received in writing to info@astct.org by or on Thursday, September 1. Refunds will not be provided beginning on Friday, September 2. Substitutions can be made, without a fee, by contacting info@astct.org

Proof of vaccination is required to attend the Clinical Education Conference. 

Health & Safety

ASTCT is continuing to monitor recommendations from the CDC and WHO. For COVID-19 updates and what to expect at the Hyatt Regency Miami, click here. Additional information regarding COVID-19 policies for the city of Miami are available here. Attendees will be required to show proof of vaccination upon checking in at the registration desk. A person is considered fully vaccinated:
  • 2 weeks after their second dose in a 2-dose series, such as the Pfizer and Moderna vaccines
  • 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine

Only vaccines authorized by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO) will be accepted. These Include:

  • Moderna
  • Pfizer/ BioNTech
  • Janssen/ Johnson & Johnson
  • Oxford/ AstraZeneca
  • CoviShield (Surem Institute of India- Oxford/AstraZeneca Formulation)
  • Sinopharm- BBBIBP-CorV

Housing 

Hyatt Regency Miami
400 SE 2nd Ave
Miami, FL 33131
Room Rate: $199 + tax per night (single/double)

The Hyatt Regency Miami requires all reservations be guaranteed with a deposit equal to one night’s room and tax. The check-in time is between 4:00pm and midnight and the check-out time is 11:00am. We understand plans change – should you need to cancel your reservation, the hotel will refund the deposit provided notice is received 48 hours prior to arrival. The cut off to secure your housing is Friday, September 16. 

Travel Arrangements

The preferred airport is Miami International Airport (MIA) which is 9.3 miles or 20 minutes by car from the hotel. The Hyatt Regency Miami is conveniently located 0.1 miles from the Downtown Shopping District, 0.3 miles from Bayfront Park, and 0.1 miles from the James L. Knight Center.

Program Agenda


Day 1: Thursday, October 13

Time

Topic

7:00 – 8:00 AM

Registration opens; exhibits open

8:00 – 8:45 AM

Best of Tandem

Stella Davies, MBBS, PhD; ASTCT Immediate Past President; Cincinnati Children's Hospital, Cincinnati, OH

8:45 – 9:30 AM

Ethical Considerations for Transplant Patients

 

Laura Connelly-Smith, BPharm, MBBCh, DM; Fred Hutchinson Cancer Research Center, Seattle, WA

9:30 – 10:15 AM

Health Disparities and Barriers to Care in Transplant Patients

 

Alexia Zadok, LCSW; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

10:15 – 10:45 AM

Break

10:45 – 11:30 AM

Advancement of Transplant Throughout the Years

Krishna Komanduri, MD, FASTCT; University of California San Francisco, San Francisco, CA

11:30 – 12:15 PM

Challenging Conversations with Patients

Caroline Morrison, Ph.D., RN, CNL; University of Cincinnati, Cincinnati, OH

12:15 – 1:15 PM

Lunch

1:15 – 2:00 PM

Roundtable: How to Set Up a Survivorship Clinic

Pepita Jean, MSN, APRN, FNP-BC, BMTCN; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
Amy Browning, MSN, AGPCNP-BC; AdventHealth Orlando; Orlando, FL
Christina Ferraro, MSN, APRN-CNP, BMTCN; Cleveland Clinic, Cleveland, OH

2:00 – 2:45 PM

I am cancer free, Now WHAT?

Pepita Jean, MSN, APRN, FNP-BC, BMTCN; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

2:45 – 3:00 PM

Break

3:00 – 4:00 PM

Chronic CAR T and Survivorship

Jay Spiegel, MD, FRCPC; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

4:00 – 6:00 PM

Networking Reception

Day 1 concludes


Day 2: Friday, October 14

Time

Topic

7:00 – 8:00 AM

Registration

Product Theater 1

Product Theater 2 

Breakout Section

Beginners Track

Adult Track

Pediatric Track

8:30 – 9:15 AM

Pre-Transplant Evaluation: Assess for Success

Sarah Basurto, BSN, RN; Cleveland Clinic, Cleveland, OH

Maintenance Therapy After Transplant

Rushang Patel, MD; AdventHealth Orlando; Orlando, FL

Not Just the Liver, Not Just the BMT Patient: VOD in the Pediatric Population, Multi-System Organ Function

Anand Srinivasan, MBBS;

University of Oklahoma Health Sciences Center, Oklahoma City, OK

 

9:15 – 10:00 AM

Choosing the Right Donor and Stem Cell Source

Amy Browning, ARNP; AdventHealth Orlando; Orlando, FL

NGS panels and Gene Mutations

Bhumika Patel, MD GHS Cancer Institute at Prima Health Cancer Institute

Re-integration into School

Neel Bhatt, MBBS, MPH; Fred Hutchinson Cancer Research Center, Seattle, WA

10:00 – 10:15 AM

Break

10:15 – 11:00 AM

Donor Work Up Evaluation

Christina Ferraro, MSN, APRN, FN-C, BMTCN; Cleveland Clinic, Cleveland, OH

Geriatric Assessment and Management in Transplantation and Cellular Therapy

Richard Lin, MD, PhD; Memorial Sloan Kettering Cancer Center, New York, NY

Pulmonary Complications including PFT Interpretations


11:00 – 11:45 AM

Post–Transplant Complications

Juan F. Ramirez, AGPNP-BC; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

Case Study: Transplant Emergencies

Mariadela Matute, MSN, APRN, BMT-CN; Miami Cancer Institute, Miami, FL

Nephrology Across the Spectrum of Newborn to Young Adults

Chryso Katsoufis, MD; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

12:30 – 1:15PM

Lunch

1:15 – 2:00 PM

Steroids: The good, the bad, and the ugly

Cory Edgar, MPAS, PA-C; AdventHealth Orlando; Orlando, FL

Pharmaceutical Review; New GVHD Products

Katrina M. Piedra, PharmD, BCOP; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

Transplant of Nonmalignant Diseases 

David Crawford, MD; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

2:00 – 3:00 PM

Assessment of the GVHD Patient

Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

COVID-19 and Vaccines in the Transplant Population

Jose Camargo Galvis, MD; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

Evolving Landscape of Treatment  Options in Chronic and Acute GVHD


Warren Alperstein, MD; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

3:00 – 3:30 PM

Break

3:30 – 4:30 PM

Panel Discussion: APP Roles and Staffing


Anita Bias, MSN,  APRN, CNP, AOCNP; Cleveland Clinic, Cleveland, OH
Liza Rodriguez, DNP, APRN, AOCNP; University of Kansas Medical Center, Kansas City, KS
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

Day 2 concludes 


Saturday, October 15

Time

Topic

7:00 – 8:00 AM

Product Theater 1

Product Theater 2

8:00 - 8:30 AM

Morning Coffee Fuel Up

8:30 – 9:30 AM

Updates in CAR T

Yvette Morlote, APRN, FNP-BC; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

9:30 – 10:15 AM

Management of the Ambulatory CAR T-Cell Patient

 

Linda Ramsdell, MSN, FNP-BC, OCN; Dana-Farber Cancer Institute, Boston, MA

10:15 – 10:45 AM

Break

10:45 – 11:30 AM

Investigational Cellular Therapies

 

Jannakie Joseph MSN, AGNP-BC; Memorial Sloan Kettering Cancer Center, New York, NY

11:30 – 12:15 PM

Acute Management of CAR T

Selgrys Cisneros, APP; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

12:15 – 1:00 PM

Improving Access to CAR T

Jannelle Vicens DNP, APRN, FNP-BC; Miami Cancer Institute, Miami, FL

Ingemar Enrique Latino, RN, BMTCN; Miami Cancer Institute, Miami, FL

Conference concludes

Sponsorship Opportunities

Please contact Angie Dahl, ASTCT Director of Development, regarding the available sponsorship opportunities at the Clinical Education Conference. Click here to view the 2022 prospectus.

Continuing Education

The Clinical Education Conference will provide 16.0 ACCME and ANCC hours of continuing education. 

Category 1
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extend of their participation in the activity. 

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

Nurse CE
Creighton University Health Sciences  Continuing Education designates this activity for 16.0 contact hours for nurses. Nurses should only claim credit commensurate with the extend of their participation in the activity. 

Accreditation
In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and the American Society for Transplantation and Cellular Therapy (ASTCT). Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.